TCL Archive First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma February 22, 2013
TCL Archive FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma. February 17, 2006